📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Clinical outcomes with second-line dolutegravir in people with virological failure on first-line non-nucleoside reverse transcriptase inhibitor-based regimens in South Africa: a retrospective cohort study. (2024)

First Author: Asare K

Attributed to: Addressing challenges in scaling up TB and HIV treatment integration in public health settings in South Africa funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/s2214-109x(23)00516-8

PubMed Identifier: 38142692

Publication URI: http://europepmc.org/abstract/MED/38142692

Type: Journal Article/Review

Volume: 12

Parent Publication: The Lancet. Global health

Issue: 2

ISSN: 2214-109X